Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy

European Journal of Surgical Oncology

Volumn 35, Issue 9, 2009, Pages 916-920

  Menard, J P ^a   Extra, J M ^a   Jacquemier, J ^a   Buttarelli, M ^a   Lambaudie, E ^a   Bannier, M ^a   Brenot Rossi, I ^a   Houvenaeghel, G ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Sentinel node

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; TRASTUZUMAB;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; FRANCE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 68249091935     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.11.002     Document Type: Article

References (25)

1. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
2. Xing Y., Foy M., Cox D.D., Kuerer H.M., Hunt K.K., and Cormier J.N. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93 (2006) 539-546
3. Cox C.E., Cox J.M., White L.B., et al. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol 13 (2006) 483-490
4. Ollila D.W., Neuman H.B., Sartor C., Carey L.A., and Klauber-Demore N. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg 190 (2005) 371-375
5. Van Rijk M.C., Nieweg O.E., Rutgers E.J.T., et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol 13 (2006) 475-479
6. Schrenk P., Hochreiner G., Fridrik M., and Wayand W. Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer. Breast J 9 (2003) 282-287
7. Jones JL, Rhei E, Gadd MA, et al. Predictive value of sentinel lymph node biopsy prior to neoadjuvant chemotherapy in clinically node negative breast cancer. American Society Clinical Oncology. Annual Meeting. 2004.
8. Jones J.L., Zabicki K., Christian R.L., et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 190 (2005) 517-520
9. Sabel S., Schott A.F., Kleer C.G., et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 186 (2003) 102-105
10. Schrenk P., Tausch C., Wölfl S., Bogner S., Fridrik M., and Wayand W. Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes. Am J Surg 196 (2008) 176-183
11. Lelievre L., Houvenaeghel G., Buttarelli M., et al. Value of the sentinel lymph node procedure in patients with large size breast cancer. Ann Surg Oncol 14 (2007) 621-626
12. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
13. Berg J.W. The significance of axillary node levels in the study of breast carcinoma. Cancer 8 (1955) 776-778
14. Kuerer H.M., Sahin A.A., Hunt K.K., et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastatses before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230 (1999) 72-78
15. Singletary S.E., Allred C., Ashley P., et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC cancer staging manual. Surg Clin North Am 83 (2003) 803-819
16. Schule J., Frisell J., Ingvar C., and Bergkvist L. Sentinel node biopsy for breast cancer larger than 3 cm in diameter. Br J Surg 94 (2007) 948-951
17. Bedrosian I., Reynolds C., Mick R., et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88 (2000) 2540-2545
18. Chung M.H., Ye W., and Giuliano A.E. Role for sentinel lymph node dissection in the management large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol 8 (2001) 688-692
19. Hennessy B.T., Hortobagyi G.N., Rouzier R., et al. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23 (2005) 9304-9311
20. Rouzier R., Extra J.M., Klijanienko J., et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20 (2002) 1304-1310
21. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
22. -Rossi B., Houvenaeghel G., Jacquemier J., et al. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?. J Nucl Med 44 (2003) 1232-1237
23. Newman E.K., Sabel M.S., Nees A.V., et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 14 (2007) 2946-2952
24. Newman L.A., Pernick N.L., Adsay V., et al. Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome. Ann Surg Oncol 10 (2003) 734-739
25. Tan L.K., Giri D., Hummer A.J., et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26 (2008) 1803-1809